Cengild Medical Berhad Statistics

Total Valuation

Cengild Medical Berhad has a market cap or net worth of MYR 208.23 million. The enterprise value is 125.95 million.

Market Cap	208.23M
Enterprise Value	125.95M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Sep 10, 2024

Share Statistics

Cengild Medical Berhad has 832.91 million shares outstanding. The number of shares has increased by 1.00% in one year.

Current Share Class	n/a
Shares Outstanding	832.91M
Shares Change (YoY)	+1.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	68.03%
Owned by Institutions (%)	0.38%
Float	169.20M

Valuation Ratios

The trailing PE ratio is 18.80.

PE Ratio	18.80
Forward PE	n/a
PS Ratio	3.11
PB Ratio	1.87
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.88, with an EV/FCF ratio of -45.01.

EV / Earnings	11.37
EV / Sales	1.88
EV / EBITDA	7.88
EV / EBIT	10.51
EV / FCF	-45.01

Financial Position

The company has a current ratio of 6.73, with a Debt / Equity ratio of 0.07.

Current Ratio	6.73
Quick Ratio	6.59
Debt / Equity	0.07
Debt / EBITDA	0.50
Debt / FCF	-2.91
Interest Coverage	19.59

Financial Efficiency

Return on equity (ROE) is 10.19% and return on invested capital (ROIC) is 6.41%.

Return on Equity (ROE)	10.19%
Return on Assets (ROA)	5.84%
Return on Capital (ROIC)	6.41%
Revenue Per Employee	420,462
Profits Per Employee	69,672
Employee Count	159
Asset Turnover	0.51
Inventory Turnover	23.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-26.15%
50-Day Moving Average	0.26
200-Day Moving Average	0.29
Relative Strength Index (RSI)	42.53
Average Volume (20 Days)	510,210

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cengild Medical Berhad had revenue of MYR 66.85 million and earned 11.08 million in profits. Earnings per share was 0.01.

Revenue	66.85M
Gross Profit	31.09M
Operating Income	12.33M
Pretax Income	15.84M
Net Income	11.08M
EBITDA	14.88M
EBIT	12.33M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 90.42 million in cash and 8.14 million in debt, giving a net cash position of 82.27 million or 0.10 per share.

Cash & Cash Equivalents	90.42M
Total Debt	8.14M
Net Cash	82.27M
Net Cash Per Share	0.10
Equity (Book Value)	111.30M
Book Value Per Share	0.13
Working Capital	84.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.94 million and capital expenditures -15.73 million, giving a free cash flow of -2.80 million.

Operating Cash Flow	12.94M
Capital Expenditures	-15.73M
Free Cash Flow	-2.80M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 46.51%, with operating and profit margins of 18.45% and 16.57%.

Gross Margin	46.51%
Operating Margin	18.45%
Pretax Margin	23.70%
Profit Margin	16.57%
EBITDA Margin	22.26%
EBIT Margin	18.45%
FCF Margin	-4.19%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 2.96%.

Dividend Per Share	0.01
Dividend Yield	2.96%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	55.64%
Buyback Yield	-1.00%
Shareholder Yield	1.96%
Earnings Yield	5.32%
FCF Yield	-1.34%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cengild Medical Berhad has an Altman Z-Score of 9.71.

Altman Z-Score	9.71
Piotroski F-Score	n/a